摘要
目的:探讨依达拉奉治疗急性脑栓塞患者的临床效果和不良反应。方法:收治急性脑栓塞患者53例,按入院顺序分为治疗组27例和对照组26例。对照组予血栓通治疗,治疗组在对照组基础上加用依达拉奉治疗。结果:治疗组总有效率明显优于对照组,前者具有神经功能恢复快且住院时间短的优势,未见严重不良反应。结论:依达拉奉治疗急性脑栓塞临床效果满意,安全性高。
Objective:To investigate the clinical effect and adverse reaction of abstract edaravone in the treatment of patients withacute cerebral embolism.Methods:53 patients with acute cerebral embolism were divided into the treatment group with 27 casesand the control group with 26 cases according to admission order.Patients in the control group were treated with xueshuantongtreatment,while in the treatment group were treated with edaravone and xueshuantong.Results:The total effective rate of thetreatment group was,which was significantly better than that of the control group,and the former had the advantages of quickrecovery and short hospitalization time,without serious adverse reaction.Conclusion:Edaravone has good clinical effect on thetreatment of acute cerebral embolism,and it also has high safety.
作者
刘伦
Liu Lun(Department of Internal Medicine-Neurology,the People's Hospital Wenshan State,Yunnan Province 663000)
出处
《中国社区医师》
2016年第7期102-103,共2页
Chinese Community Doctors
关键词
依达拉奉
急性脑栓塞
临床效果
Edaravone
Acute cerebral embolism
Clinical result
